These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37922304)

  • 21. Short-Term Changes in Albuminuria and Risk of Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus: A Post Hoc Analysis of the EMPA-REG OUTCOME Trial.
    Waijer SW; Xie D; Inzucchi SE; Zinman B; Koitka-Weber A; Mattheus M; von Eynatten M; Inker LA; Wanner C; Heerspink HJL
    J Am Heart Assoc; 2020 Sep; 9(18):e016976. PubMed ID: 32893717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of the cumulative triglyceride-glucose index with major adverse cardiovascular events in patients with type 2 diabetes.
    Tai S; Fu L; Zhang N; Yang R; Zhou Y; Xing Z; Wang Y; Zhou S
    Cardiovasc Diabetol; 2022 Aug; 21(1):161. PubMed ID: 35999546
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of Dapagliflozin on Cardiovascular Outcomes According to Baseline Kidney Function and Albuminuria Status in Patients With Type 2 Diabetes: A Prespecified Secondary Analysis of a Randomized Clinical Trial.
    Zelniker TA; Raz I; Mosenzon O; Dwyer JP; Heerspink HHJL; Cahn A; Goodrich EL; Im K; Bhatt DL; Leiter LA; McGuire DK; Wilding JPH; Gause-Nilsson I; Langkilde AM; Sabatine MS; Wiviott SD
    JAMA Cardiol; 2021 Jul; 6(7):801-810. PubMed ID: 33851953
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low-grade albuminuria is associated with early but not late carotid atherosclerotic lesions in community-based patients with type 2 diabetes.
    Li MF; Tu YF; Li LX; Lu JX; Dong XH; Yu LB; Zhang R; Bao YQ; Jia WP; Hu RM
    Cardiovasc Diabetol; 2013 Jul; 12():110. PubMed ID: 23883448
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical impact of albuminuria and glomerular filtration rate on renal and cardiovascular events, and all-cause mortality in Japanese patients with type 2 diabetes.
    Wada T; Haneda M; Furuichi K; Babazono T; Yokoyama H; Iseki K; Araki S; Ninomiya T; Hara S; Suzuki Y; Iwano M; Kusano E; Moriya T; Satoh H; Nakamura H; Shimizu M; Toyama T; Hara A; Makino H;
    Clin Exp Nephrol; 2014 Aug; 18(4):613-20. PubMed ID: 24132561
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urinary albumin-to-creatinine ratio within normal range and all-cause or cardiovascular mortality among U.S. adults enrolled in the NHANES during 1999-2015.
    Inoue K; Streja E; Tsujimoto T; Kobayashi H
    Ann Epidemiol; 2021 Mar; 55():15-23. PubMed ID: 33338645
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The ratio and difference of urine protein-to-creatinine ratio and albumin-to-creatinine ratio facilitate risk prediction of all-cause mortality.
    Chang DR; Yeh HC; Ting IW; Lin CY; Huang HC; Chiang HY; Chang SN; Tsai HC; Lo YC; Hsiao CT; Chu PL; Kuo CC
    Sci Rep; 2021 Apr; 11(1):7851. PubMed ID: 33846379
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urinary Albumin-to-Creatinine Ratio in Normal Range, Cardiovascular Health, and All-Cause Mortality.
    Mahemuti N; Zou J; Liu C; Xiao Z; Liang F; Yang X
    JAMA Netw Open; 2023 Dec; 6(12):e2348333. PubMed ID: 38113044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The relationship between low levels of albuminuria and mortality among adults without major cardiovascular risk factors.
    Claudel SE; Waikar SS; Schmidt IM; Vasan RS; Verma A
    Eur J Prev Cardiol; 2024 Jun; ():. PubMed ID: 38825979
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimal threshold of urinary albumin-to-creatinine ratio (UACR) for predicting long-term cardiovascular and noncardiovascular mortality.
    Yang ZW; Fu YB; Wei XB; Fu BQ; Huang JL; Zhang GR; Yu DQ
    Int Urol Nephrol; 2023 Jul; 55(7):1811-1819. PubMed ID: 36757657
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk of cardiovascular disease, death, and renal progression in diabetes according to albuminuria and estimated glomerular filtration rate.
    Niu J; Zhang X; Li M; Wu S; Zheng R; Chen L; Huo Y; Xu M; Wang T; Zhao Z; Wang S; Lin H; Qin G; Yan L; Wan Q; Chen L; Shi L; Hu R; Tang X; Su Q; Yu X; Qin Y; Chen G; Gao Z; Wang G; Shen F; Luo Z; Chen Y; Zhang Y; Liu C; Wang Y; Wu S; Yang T; Li Q; Mu Y; Zhao J; Bi Y; Ning G; Wang W; Lu J; Xu Y;
    Diabetes Metab; 2023 Mar; 49(2):101420. PubMed ID: 36640827
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kidney, Cardiovascular, and Safety Outcomes of Canagliflozin according to Baseline Albuminuria: A CREDENCE Secondary Analysis.
    Jardine M; Zhou Z; Lambers Heerspink HJ; Hockham C; Li Q; Agarwal R; Bakris GL; Cannon CP; Charytan DM; Greene T; Levin A; Li JW; Neuen BL; Neal B; Oh R; Oshima M; Pollock C; Wheeler DC; de Zeeuw D; Zhang H; Zinman B; Mahaffey KW; Perkovic V
    Clin J Am Soc Nephrol; 2021 Mar; 16(3):384-395. PubMed ID: 33619120
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stronger Association of Albuminuria with the Risk of Vascular Complications than Estimated Glomerular Filtration Rate in Type 2 Diabetes.
    Hong X; Huang L; Zhang Y; Shen X; Weng S; Zeng F; Zhao F; Yan S
    Kidney Blood Press Res; 2021; 46(5):550-562. PubMed ID: 34428770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does albuminuria predict cardiovascular outcomes on treatment with losartan versus atenolol in patients with diabetes, hypertension, and left ventricular hypertrophy? The LIFE study.
    Ibsen H; Olsen MH; Wachtell K; Borch-Johnsen K; Lindholm LH; Mogensen CE; Dahlöf B; Snapinn SM; Wan Y; Lyle PA
    Diabetes Care; 2006 Mar; 29(3):595-600. PubMed ID: 16505512
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sex modifies the association between urinary albumin-to-creatinine ratio and diabetes among adults in the United States (NHANES 2011-2018).
    Shi Y; Hu H; Wu Z; Wu J; Chen Z; Li P
    Biol Sex Differ; 2022 Sep; 13(1):53. PubMed ID: 36175972
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kidney Function as Risk Factor and Predictor of Cardiovascular Outcomes and Mortality Among Older Adults.
    Kühn A; van der Giet M; Kuhlmann MK; Martus P; Mielke N; Ebert N; Schaeffner ES
    Am J Kidney Dis; 2021 Mar; 77(3):386-396.e1. PubMed ID: 33197533
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Individual variability in response to renin angiotensin aldosterone system inhibition predicts cardiovascular outcome in patients with type 2 diabetes: A primary care cohort study.
    Apperloo EM; Pena MJ; de Zeeuw D; Denig P; Heerspink HJL
    Diabetes Obes Metab; 2018 Jun; 20(6):1377-1383. PubMed ID: 29345404
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of Empagliflozin Treatment With Albuminuria Levels in Patients With Heart Failure: A Secondary Analysis of EMPEROR-Pooled.
    Ferreira JP; Zannad F; Butler J; Filippatos G; Pocock SJ; Brueckmann M; Steubl D; Schueler E; Anker SD; Packer M
    JAMA Cardiol; 2022 Nov; 7(11):1148-1159. PubMed ID: 36129693
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression levels of serum vasohibin-1 and other biomarkers in type 2 diabetes mellitus patients with different urinary albumin to creatinine ratios.
    Ren H; Shao Y; Ma X; Yang M; Liu Y; Wang Q
    J Diabetes Complications; 2019 Jul; 33(7):477-484. PubMed ID: 31097304
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in Albuminuria Predict Cardiovascular and Renal Outcomes in Type 2 Diabetes: A Post Hoc Analysis of the LEADER Trial.
    Persson F; Bain SC; Mosenzon O; Heerspink HJL; Mann JFE; Pratley R; Raz I; Idorn T; Rasmussen S; von Scholten BJ; Rossing P;
    Diabetes Care; 2021 Apr; 44(4):1020-1026. PubMed ID: 33504496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.